Back to main

In Insider Trading, Biopharma Companies Synta Pharmaceuticals and Epizyme See Purchases

Posted
6/7/2013 12:35:00 PM
By: Minyanville
Referenced Stocks:EPZM;MVC;SNTA;UBNT

Welcome to our daily roundup of top insider trades. Here's a look at the most significant inside sales and purchases filed with the SEC on Thursday, June 6, 2013.

Notable Purchases:

Notable Sale:
For more insider trades, please see the chart below:

Insider Purchases
#: Filer Name Insider Titles Company Name Ticker Trans
Type
Dollar Value

1

Summit Midstream

DIR,BO

Summit Midstream

SMLP

JB*

$48,992,860

2

Kovner Bruce

DIR,BO

Synta Pharm

SNTA

B

$9,270,354

3

Harbinger

BO

Spectrum Brands

SPB

B

$3,882,662

4

Keene Harold L

DIR,BO

New Peoples Bk

NWPP

JB*

$1,050,000

5

Celgene Euro Inv

BO

Epizyme

EPZM

JB*

$999,990

6

Goldstein Phillip

DIR

MVC Capital

MVC

B

$334,590

7

Rosenfeld Ronald

DIR

NY Com Banc

NYCB

B

$261,370

8

Astellas Venture Fund I

BO

Epizyme

EPZM

JB*

$229,995

9

Keller Wilhelm

DIR

Biologix Hair

BLGX

JB*

$200,000

10

Zelter James C

CEO,DIR

Apollo Investment

AINV

B

$159,200


Insider Sales
#: Filer Name Insider Titles Company Name Ticker Trans
Type
Dollar Value

1

Summit Partners PE Fund Vii A

BO

Ubiquiti Networks

UBNT

JS*

$96,000,000

2

Greenspring Assoc

BO

Exacttarget

ET

S

$78,013,920

3

Wilson Dennis J

DIR,BO

Lululemon Athletica

LULU

AS

$32,130,882

4

Gross Robert G

DIR

Monro Muffler

MNRO

S

$6,347,083

5

Andreotti Lamberto

CEO,DIR

Bristol Myers

BMY

S

$4,774,000

6

Franklin Martin E

CB,DIR

Jarden

JAH

AS

$4,591,092

7

Wilson Laurence

GC,SEC

YELP

YELP

AS

$3,878,568

8

Ashken Ian G H

VCB,CFO,DIR

Jarden

JAH

AS

$2,754,000

9

Tutor Ronald N

CB,CEO,BO

Tutor Perini

TPC

S

$1,957,892

10

Stiefler Jeffrey E

DIR

Lpl Financial

LPLA

S

$1,745,304

Source: InsiderInsights.com | Key to Insider Title and Trans Type Codes

An important note from Jonathan Moreland, founder of Insider Insights :

In a victory for common sense, it has been proven profitable -- by both academic studies and (more importantly) the experience of your fellow professional investors -- to monitor the trading behavior of company executives, directors, and large shareholders in the stocks of firms of which they're registered as "insiders."

Please note, however, that the lists above are strictly factual; they are not buy and sell recommendations. Dollar value is only one metric to assess the importance of an insider transaction, and, frankly, often not even the most important metric that determines if an insider transaction is significant.

At InsiderInsights.com, we find new investment ideas just about every day using these and more intricate insider screens to determine where we should focus our subsequent fundamental and technical analysis. And while stocks don't (or shouldn't) move up or down based on insider activity alone, insiders tend to be good indicators of when real stock-moving events like earnings surprises, corporate actions, and new products may be in the offing.

Jonathan Moreland is also the author of " Profit From Legal Insider Trading."